Reuters logo
BRIEF-Oryzon Genomics gets approval in Spain to start PhIIA clinical trial in MS with ORY-2001
October 30, 2017 / 5:35 PM / 19 days ago

BRIEF-Oryzon Genomics gets approval in Spain to start PhIIA clinical trial in MS with ORY-2001

Oct 30 (Reuters) - ORYZON GENOMICS SA:

* GETS APPROVAL FROM SPANISH MEDICINE AGENCY (AGENCIA ESPANOLA DEL MEDICAMENTO, AEMPS) TO START PHIIA CLINICAL TRIAL WITH ORY-2001 IN PATIENTS OF MULTIPLE SCLEROSIS

* EXPECTS TO START ENROLLMENT BEFORE YEAR‘S END ‍​ Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below